Tumor News and Research

RSS

MD Anderson introduces Moon Shots Program to reduce cancer deaths

The University of Texas MD Anderson Cancer Center announces the launch of the Moon Shots Program, an unprecedented effort to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths.

21 Sep 2012

Isolating and concentrating cells from whole blood: an interview with Victor Ugaz

There are several reasons for this. One is because analysis involving different kinds of blood cells may require you to be able to separate red blood cells from white blood cells, or plasma from whole blood etc.

21 Sep 2012

Caltech biologists gain new insight into migrating cells

At any given moment, millions of cells are on the move in the human body, typically on their way to aid in immune response, make repairs, or provide some other benefit to the structures around them. When the migration process goes wrong, however, the results can include tumor formation and metastatic cancer. Little has been known about how cell migration actually works, but now, with the help of some tiny worms, researchers at the California Institute of Technology (Caltech) have gained new insight into this highly complex task.

21 Sep 2012

Study identifies factors that contribute to solid stress within tumors

It's a high-pressure environment within solid tumors. Abnormal blood and lymphatic vessels cause fluids to accumulate, and the uncontrolled proliferation of cancer cells within limited space leads to the buildup of what is called solid stress.

21 Sep 2012

Data from Navidea’s Lymphoseek Phase 3 studies on solid tumors to be presented at ESSO

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that data from its completed Phase 3 Lymphoseek studies in breast cancer and melanoma are being presented at the 32nd Congress of the European Society of Surgical Oncology (ESSO) in Valencia, Spain, from September 19-21, 2012.

21 Sep 2012

Systems biologist to pursue research into next-generation genome sequencing technology

Systems biologist Edward Marcotte has received a $2.5 million grant from the National Institutes of Health to pursue cutting-edge research in the area of genome sequencing technology.

21 Sep 2012

Recurrent glioblastoma: consider after effects before choosing palliative surgery

Before suggesting surgery as palliative therapy for patients with recurrent glioblastoma, physicians should consider the impact of morbidities on quality of life, suggest researchers from Italy.

20 Sep 2012

Molecular disruptions in granule cells cause epileptic seizures in mice

Scientists have discovered the first direct evidence that a biological mechanism long suspected in epilepsy is capable of triggering brain seizures – opening the door for studies to seek improved treatments or even preventative therapies.

20 Sep 2012

Tel Aviv University researcher discovers homing device that draws cancer

The process of metastasis, by which cancer cells travel from a tumor site and proliferate at other sites in the body, is a serious threat to cancer patients. According to the National Cancer Institute, most recurrences of cancer are metastases rather than "new" cancers.

20 Sep 2012

New 3D endoscope at UMDNJ-The University Hospital can treat complex neurosurgical diseases

Ana Cores, a 54-year old Hackensack resident, worried about how a sudden loss of peripheral vision would impact the quality of her life. After undergoing MRIs, eye exams and many diagnostic tests, Cores opted to visit UMDNJ-The University Hospital where Dr. James K. Liu, a skull base neurosurgeon, and Dr. Jean Anderson Eloy, an otolaryngologist, used a new three- dimensional endoscope to remove a brain tumor through her nose that was pressing on her optic nerve and causing her to go blind.

20 Sep 2012

RRM2 may be a facilitating factor in colorectal cancer and UV-induced DNA damage repair

Colorectal cancer (CRC) is the leading cause of cancer-related death worldwide. In addition, the incidence and mortality rates of colorectal cancer are on the rise. Recently, metabolic genes have received increasing and specific attention due to their potential role in carcinogenesis.

20 Sep 2012

Complete story behind connection between XMRV virus and prostate cancer

A once-promising discovery linking prostate cancer to an obscure retrovirus derived from mice was the result of an inadvertent laboratory contamination, a forensic analysis of tissue samples and lab experiments - some dating back nearly a decade - has confirmed.

20 Sep 2012

UC San Diego’s bold plan aims to personalize cancer treatment

UC San Diego Moores Cancer Center launched a bold plan today aimed at personalizing cancer treatment. The "My Answer to Cancer" team of oncologists, bioinformaticians, pathologists and geneticists pledges to "sequence" or analyze the DNA of large numbers of patients with cancer in order to match each patient to the best available drug for his or her particular tumor.

19 Sep 2012

Positive data from Aprea’s APR-246 Phase I/II study on blood or prostate cancer

Aprea today announced positive data from a completed Phase I/II clinical study with its investigational drug APR-246. The results from the study have been published in the Journal of Clinical Oncology.

18 Sep 2012

SPECT/CT detects metastatic nodes in melanoma

The preoperative use of single-photon emission CT plus CT imaging improves the detection of metastatic lymph nodes over standard lymphoscintigraphy, research shows.

17 Sep 2012

Novel drug combination for patients with NRAS-mutant melanoma

A new study published online in Nature Medicine, led by scientists at The University of Texas MD Anderson Cancer Center, describes the discovery of a novel drug combination aimed at a subset of melanoma patients who currently have no effective therapeutic options.

17 Sep 2012

Jennerex Phase 2 JX-594 clinical data for hepatocellular carcinoma presented at ILCA meeting

Jennerex, Inc., a private, clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic immunotherapies, presented Phase 2 clinical data of JX-594 delivered first intravenously and subsequently through intra-tumoral route demonstrating safety as well as disease control and tumor responses in patients with hepatocellular carcinoma (liver cancer, HCC).

17 Sep 2012

Progenra’s P5091 inhibits growth of bortezomib resistant multiple myeloma tumor cells

Researchers at the Dana-Farber Cancer Institute and Progenra, Inc. announce the publication of a research article entitled "A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance."

17 Sep 2012

PARP inhibitors may be novel treatment strategy in women with HER2-positive breast cancers

Poly (ADP-Ribose) polymerase (PARP) inhibitors, shown to have clinical activity when used alone in women with familial breast and ovarian cancers linked to BRCA mutations, may be a novel treatment strategy in women with HER2-positive breast cancers, according to the results of a study published in Cancer Research, a journal of the American Association for Cancer Research.

17 Sep 2012

Study could reveal whether breast cancer patients with BRCA mutations are responsive to Veliparib

Ongoing research at the Methodist Cancer Center could reveal whether metastatic breast cancer patients with BRCA gene mutations are particularly responsive to a drug regimen that includes Veliparib, an investigational drug believed to hamper cancer cells.

15 Sep 2012

Tumor News and Research

MD Anderson introduces Moon Shots Program to reduce cancer deaths

Isolating and concentrating cells from whole blood: an interview with Victor Ugaz

Caltech biologists gain new insight into migrating cells

Study identifies factors that contribute to solid stress within tumors

Data from Navidea’s Lymphoseek Phase 3 studies on solid tumors to be presented at ESSO

Systems biologist to pursue research into next-generation genome sequencing technology

Recurrent glioblastoma: consider after effects before choosing palliative surgery

Molecular disruptions in granule cells cause epileptic seizures in mice

Tel Aviv University researcher discovers homing device that draws cancer

New 3D endoscope at UMDNJ-The University Hospital can treat complex neurosurgical diseases

RRM2 may be a facilitating factor in colorectal cancer and UV-induced DNA damage repair

Complete story behind connection between XMRV virus and prostate cancer

UC San Diego’s bold plan aims to personalize cancer treatment

Positive data from Aprea’s APR-246 Phase I/II study on blood or prostate cancer

SPECT/CT detects metastatic nodes in melanoma

Novel drug combination for patients with NRAS-mutant melanoma

Jennerex Phase 2 JX-594 clinical data for hepatocellular carcinoma presented at ILCA meeting

Progenra’s P5091 inhibits growth of bortezomib resistant multiple myeloma tumor cells

PARP inhibitors may be novel treatment strategy in women with HER2-positive breast cancers

Study could reveal whether breast cancer patients with BRCA mutations are responsive to Veliparib

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News